Nomenclature	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1249	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1250	http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1251
Common abbreviation	eNOS	iNOS	nNOS
HGNC, UniProt	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:7876, http://www.uniprot.org/uniprot/P29474	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:7873, http://www.uniprot.org/uniprot/P35228	https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:7872, http://www.uniprot.org/uniprot/P29475
EC number	http://www.genome.jp/dbget‐bin/www_bget?ec:1.14.13.39	http://www.genome.jp/dbget‐bin/www_bget?ec:1.14.13.39	http://www.genome.jp/dbget‐bin/www_bget?ec:1.14.13.39
Endogenous Substrate	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=721	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=721	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=721
Products	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2509, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=722	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2509, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=722	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=722, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2509
Cofactors	oxygen, BH4, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=566, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5185, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3041, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4349, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5184	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4349, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5185, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5184, oxygen, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3041, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=566, BH4	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5184, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4349, oxygen, BH4, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5185, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3041, http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=566
Selective inhibitors	–	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5102 (pIC50 8.2) [http://www.ncbi.nlm.nih.gov/pubmed/9030556?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5111 (pIC50 7.4) [http://www.ncbi.nlm.nih.gov/pubmed/8937711?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5246 (pIC50 7.3) [http://www.ncbi.nlm.nih.gov/pubmed/7523409?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5231 (pIC50 5.5) [http://www.ncbi.nlm.nih.gov/pubmed/7525961?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5135 [http://www.ncbi.nlm.nih.gov/pubmed/1378415?dopt=AbstractPlus]	http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5113 (pIC50 6.1–6.5) [http://www.ncbi.nlm.nih.gov/pubmed/7544863?dopt=AbstractPlus], http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5127 (pIC50 5.3) [http://www.ncbi.nlm.nih.gov/pubmed/7693279?dopt=AbstractPlus]